Edgewell cuts FY2025 adjusted EPS outlook to about $2.65 after Q3 adjusted EPS falls to $0.92
Edgewell Personal Care reported third-quarter fiscal 2025 net sales of $627.2 million, down 3.2%, with adjusted EPS of $0.92 versus $1.22 a year earlier. The company lowered its full-year fiscal 2025 outlook, including adjusted EPS of about $2.65 versus a prior range of $2.85 to $3.05, citing weak Sun Care seasons, tariffs and foreign exchange, which points to lower profit and cash generation for shareholders this year.
Key points
- Q3 net sales were $627.2 million, down 3.2%; organic net sales fell 4.2% and North America organic sales fell 8.0%.
- Q3 GAAP diluted EPS was $0.62 versus $0.98, and adjusted EPS was $0.92 versus $1.22 in the prior year quarter.
- FY2025 adjusted EPS is now expected to be about $2.65 (previously $2.85 to $3.05); GAAP EPS is now about $1.73 (previously $2.09 to $2.29).
- FY2025 free cash flow is now expected to be about $80 million (previously $130 million to $140 million); the board declared a $0.15 quarterly dividend payable October 8, 2025.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:57 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 05, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.